Supplements

Is Dong Quai Safe? What the Research Actually Says

Dong quai is one of the most widely purchased women's herbs in the US, yet most labels omit its coumarin content, phototoxic compounds, and drug interaction profile. Understanding those risks — and the populations most affected — is essential before adding it to any supplement routine.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
dong quaiAngelica sinensiswomen's healthherbal supplementssupplement safety
Is Dong Quai Safe? What the Research Actually Says

Is Dong Quai Safe? What the Research Actually Says

For most healthy, non-pregnant adults, dong quai is reasonably safe at typical culinary and low-supplement doses, but it carries meaningful risks at higher doses or in specific populations. It contains coumarin derivatives that thin the blood, phototoxic compounds that can damage skin in sunlight, and weak estrogen-like activity that matters for anyone on hormonal medications or with hormone-sensitive conditions. Pregnant women and people on anticoagulants should avoid it entirely.

---

What Is Dong Quai and Why Do People Take It?

Dong quai (Angelica sinensis) is the dried root of a plant native to China, Korea, and Japan. It has been used in traditional East Asian medicine for over 2,000 years, most often for menstrual irregularity, menopausal symptoms, and circulatory complaints. In the modern supplement market it shows up as capsules, tinctures, and teas, frequently marketed to women as a natural hormone balancer.

The root contains several bioactive compound classes:

  • Phthalides (notably Z-ligustilide): smooth muscle relaxants with analgesic and anti-inflammatory properties
  • Coumarins (osthole, isoimperatorin, psoralen): anticoagulant and phototoxic effects
  • Polysaccharides: immunomodulatory activity
  • Ferulic acid: antioxidant, also found in many whole grains

The estrogenic activity of dong quai is weaker and more nuanced than many herb databases suggest. A landmark in vitro study by Amato et al. found that Angelica sinensis extracts showed both estrogenic and anti-estrogenic activity depending on cell type and estradiol environment, which means blanket labeling it an "estrogen herb" oversimplifies the pharmacology considerably (Amato et al., Menopause 2002; PMID: 12438839).

---

The Coumarin Problem: Anticoagulant and Phototoxic Risk

The most clinically important safety signal for dong quai is its coumarin content. Coumarins are a family of compounds that inhibit vitamin K-dependent clotting factor synthesis — the same mechanism exploited by warfarin. The specific coumarins in Angelica sinensis include psoralen, bergapten, and isoimperatorin. Psoralen and bergapten are also furanocoumarins: they intercalate into DNA when activated by UVA light, causing photodermatitis, hyperpigmentation, and in high doses, blistering burns.

A case report published in the journal Pharmacotherapy documented severe photosensitivity dermatitis in a woman taking dong quai capsules who then received UV phototherapy for psoriasis — her burn was dramatically worse than expected because the furanocoumarin content of her supplement was not disclosed to her dermatologist (Goh & Ng, Pharmacotherapy 2006; PMID: 16503720). This is not a theoretical risk.

On the anticoagulant side, a case published in Annals of Internal Medicine described a patient stabilized on warfarin whose INR rose from a therapeutic 2–3 to a dangerous 4.9 after starting dong quai, with no other changes to medication or diet. The INR normalized within a month of discontinuation (Ellis & Stephens, Annals of Internal Medicine 1997; PMID: 9188935). Even at doses people consider "herbal" and gentle, the coumarin load can meaningfully potentiate anticoagulant therapy.

Practical implication: Anyone on warfarin, heparin, apixaban, rivaroxaban, clopidogrel, or aspirin at antiplatelet doses should treat dong quai as contraindicated, not merely cautionary.

---

Does Dong Quai Actually Work for Menopausal Symptoms?

This is where the evidence gets inconvenient for supplement marketers. The most rigorous standalone trial — a 24-week, double-blind, randomized controlled trial by Hirata et al. in 71 postmenopausal women — found no significant difference between dong quai (4.5 g/day dried root equivalent) and placebo on hot flash frequency, endometrial thickness, vaginal cell maturation, or serum estradiol levels (Hirata et al., Fertility and Sterility 1997; PMID: 9496184). Hot flash frequency fell by about 25% in the dong quai group, but the placebo group fell by 23% — statistically indistinguishable.

What this trial cannot tell us is whether dong quai works as part of a multi-herb formula, which is closer to its traditional use. In Traditional Chinese Medicine (TCM), dong quai is almost never used alone; it typically appears alongside astragalus, ligusticum, and peony in formulas like Si Wu Tang. The isolated-herb trial design may be asking the wrong question. That said, the burden of proof for marketing a standalone supplement lies with the manufacturer, and that proof currently does not exist in randomized trial form.

For menstrual pain specifically, there is slightly more mechanistic support. Z-ligustilide, a major phthalide, has been shown in animal models to relax uterine smooth muscle and inhibit prostaglandin synthesis, which is the same pathway targeted by NSAIDs like ibuprofen. Human trials on this specific endpoint are still limited, but the mechanism is plausible and worth watching as research matures.

---

Dong Quai Overdose Symptoms

At doses above typical supplement levels — generally considered above 4–6 g per day of dried root equivalent — the risk of adverse effects escalates. Recognizable dong quai overdose symptoms include:

  • Unusual bruising or bleeding: gum bleeding, nosebleeds, prolonged bleeding from cuts
  • Photosensitivity: exaggerated sunburn after brief UV exposure, especially on skin exposed without sunscreen
  • Gastrointestinal distress: nausea, bloating, and loose stools from the volatile oil content
  • Headache and dizziness: linked to vasodilatory phthalide activity
  • Fever: documented in rare case reports of high-dose use
  • Skin rash: particularly in fair-skinned individuals after sun exposure

There is no established human LD50 for dong quai, and acute fatal overdose from a typical supplement appears to be exceedingly rare in the published literature. The practical toxicity risk is chronic rather than acute — cumulative coumarin exposure potentiating bleeding events, or cumulative photosensitizer exposure causing chronic skin damage.

If you are experiencing unusual bleeding or severe photosensitivity while taking dong quai, discontinue it and consult a healthcare provider before restarting. These symptoms can indicate that your coumarin load is exceeding what your liver is efficiently clearing.

---

Signs of Dong Quai Deficiency

It is important to state clearly: there is no recognized "dong quai deficiency" syndrome in evidence-based medicine. Dong quai is not an essential nutrient, a vitamin, or a mineral. The human body has no physiological requirement for Angelica sinensis root. This stands in contrast to genuine deficiency states like signs of vitamin B3 deficiency or vitamin C deficiency symptoms, which have well-defined clinical presentations and validated biomarkers.

What some practitioners loosely describe as "indications for dong quai" — dysmenorrhea, irregular cycles, menopausal vasomotor symptoms — are symptoms of underlying hormonal or inflammatory imbalances, not evidence of a specific herbal deficiency. Treating these symptoms with dong quai may or may not be appropriate depending on their root cause, but framing the rationale as correcting a "deficiency" is inaccurate and can mislead consumers into skipping a proper diagnostic workup.

If you are experiencing dysmenorrhea, menstrual irregularity, or menopausal symptoms, the appropriate first step is lab evaluation — not herb purchasing.

---

Dong Quai Morning or Night: Does Timing Matter?

There is no published pharmacokinetic trial specifically comparing morning versus nighttime dosing of dong quai in humans. That said, rational timing can be derived from its pharmacological profile:

  • Z-ligustilide is a smooth muscle relaxant with mild sedative properties in animal models. This weakly favors evening dosing if the primary goal is pelvic pain or cramping relief.
  • Coumarin compounds have a roughly 8–12 hour half-life. Since anticoagulant effects are cumulative rather than time-of-dose dependent, morning versus evening makes little difference for the bleeding risk profile.
  • Gastrointestinal tolerance may favor dosing with a meal regardless of time of day, because the volatile oil fraction is the primary irritant and food slows gastric emptying.

Practically, most TCM formulations and commercial supplements recommend dividing the daily dose across two administrations (morning and evening) to maintain more stable plasma levels of the active constituents. A single large dose taken all at once amplifies peak volatile oil exposure and is more likely to cause nausea.

---

Dong Quai With Food or Empty Stomach

The question of whether to take dong quai with food or on an empty stomach has a clearer answer than timing: with food, consistently.

The primary reason is gastrointestinal. The volatile oil content — particularly ferulic acid esters and phthalides — can irritate gastric mucosa when delivered directly to an empty stomach. In clinical surveys of supplement adverse events, nausea and bloating are among the most frequently reported complaints with dong quai, and they occur significantly more often in fasted users.

There is also a secondary absorption argument. Fat-soluble constituents including the furocoumarins and Z-ligustilide have better lymphatic absorption in the presence of dietary fat. This mirrors findings in other fat-soluble phytocompounds: for example, research on quercetin absorption shows a roughly 2–5× increase in bioavailability when taken with a lipid-containing meal. The phthalide fraction of dong quai is similarly lipophilic and likely follows the same absorption pattern, though human pharmacokinetic studies on this specific point are limited.

A practical protocol: take dong quai with your largest meal of the day. If you split your dose morning and evening, pair each with at least 10–15 g of dietary fat.

---

Drug Interactions Beyond Warfarin

The warfarin interaction is the best documented, but dong quai's interaction profile extends further:

Drug ClassMechanism of InteractionClinical Risk Level
Warfarin / other anticoagulantsCoumarin additive effect, INR elevationHigh — contraindicated
Tamoxifen / SERMsPotential estrogen receptor competition or synergyModerate — avoid
Oral contraceptives / HRTUnclear additive estrogenic loadModerate — caution
NSAIDs / aspirinAdditive platelet inhibitionModerate — monitor
CYP1A2 substratesFerulic acid may weakly inhibit CYP1A2Low — theoretical
Photosensitizing drugs (fluoroquinolones, tetracyclines)Additive furocoumarin phototoxicityModerate — caution

If you are taking any medication in the moderate or high risk categories above, consult a pharmacist or prescribing clinician before adding dong quai.

---

Populations Who Should Avoid Dong Quai

  1. Pregnant women — phthalides stimulate uterine smooth muscle contraction; dong quai is classified as a uterine stimulant and is associated with miscarriage risk in animal models.
  2. Breastfeeding women — insufficient safety data; the coumarin and phthalide content means potential exposure to the infant.
  3. Anyone on anticoagulants — INR destabilization risk is well documented.
  4. People with hormone-sensitive cancers — breast, ovarian, or endometrial cancer history warrants avoidance given the unclear estrogen receptor activity.
  5. Individuals with photodermatitis or porphyria — furocoumarin load will exacerbate both conditions.
  6. Children — no pediatric safety data exists; avoid.

---

What This Means for Your Formula

Dong quai does not sit in Ones' ingredient catalog as a standalone active, and that reflects a deliberate evidence threshold. At Ones, ingredients are selected based on the strength of human clinical data, the ability to standardize active constituent delivery, and a favorable safety profile across diverse users. Dong quai's variable coumarin and phthalide content across suppliers — combined with the lack of controlled efficacy data for its most marketed uses — means it cannot be dosed predictably in a personalized formula without real risk of harm.

That said, the underlying hormonal and inflammatory concerns that drive people toward dong quai are addressable with ingredients that have cleaner evidence. If lab results or wearable data suggest elevated cortisol, disrupted estrogen metabolism, or systemic inflammation, Ones may include:

  • KSM-66 Ashwagandha (600 mg): the most studied standardized ashwagandha extract for cortisol normalization. An 8-week RCT in 58 adults found KSM-66 at 300 mg twice daily reduced serum cortisol by 27.9% versus 7.9% in placebo (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798).
  • Omega-3 (EPA/DHA): EPA at ≥ 1,000 mg/day has been shown to reduce prostaglandin-driven menstrual pain through COX pathway modulation, with a meta-analysis of 9 RCTs confirming significant reduction in dysmenorrhea severity compared to placebo or ibuprofen (Rahbar et al., Complementary Therapies in Clinical Practice 2012; PMID: 22196580). If you're considering whether your omega-3 intake is in the right range, understanding omega-3 overdose symptoms is a useful starting point.
  • Ones Endocrine Support blend: a proprietary multi-ingredient system designed to support hormonal signaling, included when the AI identifies relevant biomarker patterns in a user's data.

The AI practitioner behind Ones evaluates your blood work and health history to determine whether these ingredients belong in your formula and at what dose — rather than leaving those decisions to a label's generic recommendation.

---

Key Takeaways

  • Dong quai is reasonably safe for healthy, non-pregnant adults at low supplement doses, but its coumarin and furocoumarin content creates real risks for people on anticoagulants, photosensitizing medications, or with hormone-sensitive cancers.
  • The best-controlled clinical trial found no statistically significant benefit over placebo for menopausal hot flashes when dong quai was used as a standalone supplement.
  • There is no such thing as a "dong quai deficiency" — the symptoms people take it for reflect hormonal or inflammatory imbalances that warrant proper diagnostic evaluation.
  • Take dong quai with food and fat to minimize GI irritation and improve absorption of lipophilic constituents; split dosing morning and evening is preferable to a single large dose.
  • The warfarin-dong quai interaction is well documented and clinically significant — INR can rise to dangerous levels with no change in drug dose.
  • Pregnant women and those with hormone-sensitive cancers should avoid dong quai entirely; children should not take it due to complete absence of pediatric safety data.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading